New breast cancer classification system predicts immunotherapy response success
Researchers from the Chinese Academy of Sciences have developed a new classification system to better predict how breast cancer patients respond to immunotherapy. This aims to address the high failure rate of current immune checkpoint inhibitor treatments.
Why it matters
Improving predictive models for cancer treatment can significantly increase survival rates and reduce ineffective medical interventions.
Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermatology Diabetes Eating Disorders Eye Health Gastrointestinal Health Heart Disease Lung Cancer Mental Health Parkinson's Disease Pregnancy Sleep Urology View Health A-Z Top Health Categories Coronavirus Disease COVID-19 Eating Disorders Diet & Nutrition Eye Health Artificial Intelligence Gastrointestinal Health Allergies Heart Disease Alzheimer's & Dementia Lung Cancer Arthritis & Rheumatology Mental Health Breast Cancer Parkinson's Disease Breastfeeding Pregnancy Cold, Flu & Cough Sleep Dermatology Urology Diabetes View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Webinars eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member New breast cancer classification system predicts immunotherapy response success Download PDF Copy Add News Medical on Google as a preferred source Chinese Academy of Sciences Jul 3 2026 Reviewed The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies. The cancer-immunity cycle (CIC) is a conceptual framework that maps the step-by-step process of the anti-tumor immune response, from the release of cancer cell antigens to the killing of tumor cells by T cells. A defect in any single step can halt the entire cycle and render immunotherapy ineffective. However, most research has focused on individual steps, which fails to capture the complexity of the immune response. Due to these limitations, a more holistic and systematic approach is urgently needed to accurately assess a patient's immune status and guide treatment decisions.
The article is a scientific report on medical research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in